Michael Busch

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Lanteri Marion C; O'Brien Katie M; Purtha Whitney E; Cameron Mark J; Lund Jennifer M; Owen Rachel E; Heitman John W; Custer Brian; Hirschkorn Dale F; Tobler Leslie H; Kiely Nancy; Prince Harry E; Ndhlovu Lishomwa C; Nixon Douglas F; Kamel Hany T; Kelvin David J; Busch Michael P; Rudensky Alexander Y; Diamond Michael S; Norris Philip J
Tregs control the development of symptomatic West Nile virus infection in humans and mice.
Page Kimberly; Hahn Judith A; Evans Jennifer; Shiboski Stephen; Lum Paula; Delwart Eric; Tobler Leslie; Andrews William; Avanesyan Lia; Cooper Stewart; Busch Michael P
Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.
Ma Zhong-Min; Stone Mars; Piatak Mike; Schweighardt Becky; Haigwood Nancy L; Montefiori David; Lifson Jeffrey D; Busch Michael P; Miller Christopher J
High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Michael Busch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Lanteri Marion C; O'Brien Katie M; Purtha Whitney E; Cameron Mark J; Lund Jennifer M; Owen Rachel E; Heitman John W; Custer Brian; Hirschkorn Dale F; Tobler Leslie H; Kiely Nancy; Prince Harry E; Ndhlovu Lishomwa C; Nixon Douglas F; Kamel Hany T; Kelvin David J; Busch Michael P; Rudensky Alexander Y; Diamond Michael S; Norris Philip J
Tregs control the development of symptomatic West Nile virus infection in humans and mice.
The Journal of clinical investigation 2009;119(11):3266-77.
2009: Page Kimberly; Hahn Judith A; Evans Jennifer; Shiboski Stephen; Lum Paula; Delwart Eric; Tobler Leslie; Andrews William; Avanesyan Lia; Cooper Stewart; Busch Michael P
Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.
The Journal of infectious diseases 2009;200(8):1216-26.
2009: Ma Zhong-Min; Stone Mars; Piatak Mike; Schweighardt Becky; Haigwood Nancy L; Montefiori David; Lifson Jeffrey D; Busch Michael P; Miller Christopher J
High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection.
Journal of virology 2009;83(7):3288-97.
2009: Custer Brian; Kamel Hany; Kiely Nancy E; Murphy Edward L; Busch Michael P
Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening.
Transfusion 2009;49(2):278-88.
2009: Norris Philip J; Lee Jar-How; Carrick Danielle M; Gottschall Jerome L; Lebedeva Mila; de Castro B R; Kleinman Steven H; Busch Michael P
Long-term in vitro reactivity for human leukocyte antigen antibodies and comparison of detection using serum versus plasma.
Transfusion 2009;49(2):243-51.
2009: Hatano Hiroyu; Delwart Eric L; Norris Philip J; Lee Tzong-Hae; Dunn-Williams Joan; Hunt Peter W; Hoh Rebecca; Stramer Susan L; Linnen Jeffrey M; McCune Joseph M; Martin Jeffrey N; Busch Michael P; Deeks Steven G
Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.
Journal of virology 2009;83(1):329-35.
2008: Mold Jeff E; Michaëlsson Jakob; Burt Trevor D; Muench Marcus O; Beckerman Karen P; Busch Michael P; Lee Tzong-Hae; Nixon Douglas F; McCune Joseph M
Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero.
Science (New York, N.Y.) 2008;322(5907):1562-5.
2008: Busch Michael P; Kleinman Steven H; Tobler Leslie H; Kamel Hany T; Norris Philip J; Walsh Irina; Matud Jose L; Prince Harry E; Lanciotti Robert S; Wright David J; Linnen Jeffrey M; Caglioti Sally
Virus and antibody dynamics in acute west nile virus infection.
The Journal of infectious diseases 2008;198(7):984-93.
2008: Tobler Leslie H; Cameron Mark J; Lanteri Marion C; Prince Harry E; Danesh Ali; Persad Desmond; Lanciotti Robert S; Norris Philip J; Kelvin David J; Busch Michael P
Interferon and interferon-induced chemokine expression is associated with control of acute viremia in West Nile virus-infected blood donors.
The Journal of infectious diseases 2008;198(7):979-83.
2008: Prince Harry E; Lapé-Nixon Mary; Yeh Cindy; Tobler Leslie H; Busch Michael P
Persistence of antibodies to West Nile virus nonstructural protein 5.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2008;43(1):102-6.
2008: Utter Garth H; Lee Tzong-Hae; Rivers Ryan M; Montalvo Lani; Wen Li; Chafets Daniel M; Reed William F; Busch Michael P
Microchimerism decades after transfusion among combat-injured US veterans from the Vietnam, Korean, and World War II conflicts.
Transfusion 2008;48(8):1609-15.
2008: Linnen Jeffrey M; Vinelli Elizabeth; Sabino Ester C; Tobler Leslie H; Hyland Catherine; Lee Tzong-Hae; Kolk Daniel P; Broulik Amy S; Collins Cynthia S; Lanciotti Robert S; Busch Michael P
Dengue viremia in blood donors from Honduras, Brazil, and Australia.
Transfusion 2008;48(7):1355-62.
2008: Lanteri Marion C; Heitman John W; Owen Rachel E; Busch Thomas; Gefter Nelly; Kiely Nancy; Kamel Hany T; Tobler Leslie H; Busch Michael P; Norris Philip J
Comprehensive analysis of west nile virus-specific T cell responses in humans.
The Journal of infectious diseases 2008;197(9):1296-306.
2008: Gill Ryan M; Lee Tzong-Hae; Utter Garth H; Reed William F; Wen Li; Chafets Dan; Busch Michael P
The TNF (-308A) polymorphism is associated with microchimerism in transfused trauma patients.
Blood 2008;111(7):3880-3.
2008: Guiltinan Anne M; Kaidarova Zhanna; Custer Brian; Orland Jennie; Strollo Angela; Cyrus Sherri; Busch Michael P; Murphy Edward L
Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors.
American journal of epidemiology 2008;167(6):743-50.
2008: Mosley J W; Operskalski E A; Tobler L H; Buskell Z J; Andrews W W; Phelps B; Dockter J; Giachetti C; Seeff L B; Busch M P;
The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.
Journal of viral hepatitis 2008;15(2):120-8.
2008: Page-Shafer Kimberly; Pappalardo Brandee L; Tobler Leslie H; Phelps Bruce H; Edlin Brian R; Moss Andrew R; Wright Teresa L; Wright David J; O'Brien Thomas R; Caglioti Sally; Busch Michael P
Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates.
Journal of clinical microbiology 2008;46(2):499-506.
2008: Benjamin Richard J; Busch Michael P; Fang Chyang T; Notari Edward P; Puren Adrian; Schoub Barry D; Tobler Leslie H; Hogrefe Wayne; du P Heyns Anthon; Stramer Susan L; Crookes Robert L
Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations.
Transfusion 2008;48(2):295-303.
2007: Kleinman Steven H; Glynn Simone A; Lee Tzong-Hae; Tobler Leslie; Montalvo Leilani; Todd Deborah; Kiss Joseph E; Shyamala Venkatakrishna; Busch Michael P;
Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
Transfusion 2007;47(10):1756-64.
2007: Utter G H; Reed W F; Lee T-H; Busch M P
Transfusion-associated microchimerism.
Vox sanguinis 2007;93(3):188-95.
2007: Klimashevskaya S; Obriadina A; Ulanova T; Bochkova G; Burkov A; Araujo A; Stramer Susan L; Tobler Leslie H; Busch Michael P; Fields Howard A
Distinguishing acute from chronic and resolved hepatitis C virus (HCV) infections by measurement of anti-HCV immunoglobulin G avidity index.
Journal of clinical microbiology 2007;45(10):3400-3.
2007: Prince Harry E; Tobler Leslie H; Yeh Cindy; Gefter Nelly; Custer Brian; Busch Michael P
Persistence of West Nile virus-specific antibodies in viremic blood donors.
Clinical and vaccine immunology : CVI 2007;14(9):1228-30.
2007: Custer Brian; Chinn Artina; Hirschler Nora V; Busch Michael P; Murphy Edward L
The consequences of temporary deferral on future whole blood donation.
Transfusion 2007;47(8):1514-23.
2007: Herring Belinda L; Bernardin Flavien; Caglioti Sally; Stramer Susan; Tobler Leslie; Andrews William; Cheng Lawrence; Rampersad Sarah; Cameron Cherie; Saldanha John; Busch Michael P; Delwart Eric
Phylogenetic analysis of WNV in North American blood donors during the 2003-2004 epidemic seasons.
Virology 2007;363(1):220-8.
2007: Tobler Leslie H; Contestable Paul; Pitina Lubov; Groth Holly; Shaffer Shirley; Blackburn Gary R; Warren Harold; Lee Stephen R; Busch Michael P
Evaluation of a new enzyme-linked immunosorbent assay for detection of Chagas antibody in US blood donors.
Transfusion 2007;47(1):90-6.
2007: Reed William; Lee Tzong-Hae; Norris Philip J; Utter Garth H; Busch Michael P
Transfusion-associated microchimerism: a new complication of blood transfusions in severely injured patients.
Seminars in hematology 2007;44(1):24-31.
2007: Tobler L H; Stramer S L; Chien D Y; Lin S; Arcangel P; Phelps B H; Cooper S L; Busch M P
Antibodies to a novel antigen in acute hepatitis C virus infections.
Vox sanguinis 2007;92(1):1-7.
2007: Bacchetti Peter; Tien Phyllis C; Seaberg Eric C; O'Brien Thomas R; Augenbraun Michael H; Kral Alex H; Busch Michael P; Edlin Brian R
Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression.
BMC infectious diseases 2007;7():145.
2006: Stramer Susan L; Custer Brian; Busch Michael P; Dodd Roger Y
Strategies for testing blood donors for West Nile virus.
Transfusion 2006;46(12):2036-7.
2006: Lee Tzong-Hae; Chafets Daniel M; Reed William; Wen Li; Yang Yunting; Chen Jennifer; Utter Garth H; Owings John T; Busch Michael P
Enhanced ascertainment of microchimerism with real-time quantitative polymerase chain reaction amplification of insertion-deletion polymorphisms.
Transfusion 2006;46(11):1870-8.
2006: Utter Garth H; Nathens Avery B; Lee Tzong-Hae; Reed William F; Owings John T; Nester Theresa A; Busch Michael P
Leukoreduction of blood transfusions does not diminish transfusion-associated microchimerism in trauma patients.
Transfusion 2006;46(11):1863-9.
2006: Kamel Hany T; Bassett Mary Beth; Custer Brian; Paden Christine J; Strollo Angela M; McEvoy Patrick; Busch Michael P; Tomasulo Peter A
Safety and donor acceptance of an abbreviated donor history questionnaire.
Transfusion 2006;46(10):1745-53.
2006: Busch Michael P
Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis.
Transfusion 2006;46(9):1624-40.
2006: Norris Philip J; Pappalardo Brandee L; Custer Brian; Spotts Gerald; Hecht Frederick M; Busch Michael P
Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection.
AIDS research and human retroviruses 2006;22(8):757-62.
2006: Killian M Scott; Norris Philip J; Rawal Bhupat D; Lebedeva Mila; Hecht Frederick M; Levy Jay A; Busch Michael P
The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody response.
AIDS research and human retroviruses 2006;22(7):640-7.
2006: Kleinman Steven H; Stramer Susan L; Brodsky Jaye P; Caglioti Sally; Busch Michael P
Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
Transfusion 2006;46(5):695-702.
2006: Busch Michael P; Wright David J; Custer Brian; Tobler Leslie H; Stramer Susan L; Kleinman Steven H; Prince Harry E; Bianco Celso; Foster Gregory; Petersen Lyle R; Nemo George; Glynn Simone A
West Nile virus infections projected from blood donor screening data, United States, 2003.
Emerging infectious diseases 2006;12(3):395-402.
2006: Barreto Claudia C; Nishyia Anna; Araújo Luciano V; Ferreira João E; Busch Michael P; Sabino Ester C
Trends in antiretroviral drug resistance and clade distributions among HIV-1--infected blood donors in Sao Paulo, Brazil.
Journal of acquired immune deficiency syndromes (1999) 2006;41(3):338-41.
2006: Busch Michael P; Glynn Simone A; Stramer Susan L; Orland Jennie; Murphy Edward L; Wright David J; Kleinman Steven;
Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
Transfusion 2006;46(3):469-75.
2006: Hare C Bradley; Pappalardo Brandee L; Busch Michael P; Karlsson Annika C; Phelps Bruce H; Alexander Steven S; Bentsen Christopher; Ramstead Clarissa A; Nixon Douglas F; Levy Jay A; Hecht Frederick M
Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(5):700-8.
2006: Heyns Anthon du P; Benjamin Richard J; Swanevelder J P Ronel; Laycock Megan E; Pappalardo Brandee L; Crookes Robert L; Wright David J; Busch Michael P
Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South Africa.
JAMA : the journal of the American Medical Association 2006;295(5):519-26.
2006: Delwart Eric; Kuhns Mary C; Busch Michael P
Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: implications for blood safety, diagnostics, treatment, and molecular epidemiology.
Journal of medical virology 2006;78 Suppl 1():S30-5.
2005: Busch Michael P; Glynn Simone A; Wright David J; Hirschkorn Dale; Laycock Megan E; McAuley Joan; Tu Yongling; Giachetti Cristina; Gallarda James; Heitman John; Kleinman Steven H;
Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
Transfusion 2005;45(12):1853-63.
2005: Barreto Claudia C; Sabino Ester C; Gonçalez Thelma T; Laycock Megan E; Pappalardo Brandee L; Salles Nanci A; Wright David J; Chamone Dalton F; Busch Michael P
Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil.
Transfusion 2005;45(11):1709-14.
2005: Tobler L H; Stramer S L; Lee S R; Baggett D; Wright D; Hirschkorn D; Walsh I; Busch M P
Performance of ORTHO HCV core antigen and trak-C assays for detection of viraemia in pre-seroconversion plasma and whole blood donors.
Vox sanguinis 2005;89(4):201-7.
2005: Roland Michelle E; Neilands Torsten B; Krone Melissa R; Katz Mitchell H; Franses Karena; Grant Robert M; Busch Michael P; Hecht Frederick M; Shacklett Barbara L; Kahn James O; Bamberger Joshua D; Coates Thomas J; Chesney Margaret A; Martin Jeffrey N
Seroconversion following nonoccupational postexposure prophylaxis against HIV.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(10):1507-13.
2005: Custer Brian; Busch Michael P; Marfin Anthony A; Petersen Lyle R
The cost-effectiveness of screening the U.S. blood supply for West Nile virus.
Annals of internal medicine 2005;143(7):486-92.
2005: Custer Brian; Johnson Eric S; Sullivan Sean D; Hazlet Tom K; Ramsey Scott D; Murphy Edward L; Busch Michael P
Community blood supply model: development of a new model to assess the safety, sufficiency, and cost of the blood supply.
Medical decision making : an international journal of the Society for Medical Decision Making 2005;25(5):571-82.
2005: Prince Harry E; Lapé-Nixon Mary; Busch Michael P; Tobler Leslie H; Foster Gregory A; Stramer Susan L
Utilization of follow-up specimens from viremic blood donors to assess the value of west nile virus immunoglobulin G avidity as an indicator of recent infection.
Clinical and diagnostic laboratory immunology 2005;12(9):1123-6.
2005: Prince Harry E; Tobler Leslie H; Lapé-Nixon Mary; Foster Gregory A; Stramer Susan L; Busch Michael P
Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.
Journal of clinical microbiology 2005;43(9):4316-20.
2005: Busch Michael P; Caglioti Sally; Robertson Eugene F; McAuley Joan D; Tobler Leslie H; Kamel Hany; Linnen Jeffrey M; Shyamala Venkatakrishna; Tomasulo Peter; Kleinman Steven H
Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.
The New England journal of medicine 2005;353(5):460-7.
2005: Lee Tzong-Hae; Paglieroni Teresa; Utter Garth H; Chafets Daniel; Gosselin Robert C; Reed William; Owings John T; Holland Paul V; Busch Michael P
High-level long-term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury.
Transfusion 2005;45(8):1280-90.
2005: Diaz Ricardo Sobhie; Pardini Regina; Catroxo Márcia; Operskalski Eva A; Mosley James W; Busch Michael P
HIV-1 superinfection is not a common event.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;33(4):328-30.
2005: Mosley James W; Operskalski Eva A; Tobler Leslie H; Andrews William W; Phelps Bruce; Dockter Janel; Giachetti Cristina; Busch Michael P
Viral and host factors in early hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2005;42(1):86-92.
2005: Schmidt Michael; Weber Marijke; Busch Michael P; Tobler Leslie H; Phelps Bruce H; Seifried Erhard; Roth W Kurt
Yield of hepatitis C virus nucleic acid testing among antibody-reactive or confirmed-positive samples.
Transfusion 2005;45(6):1040-2.
2005: Glynn Simone A; Wright David J; Kleinman Steven H; Hirschkorn Dale; Tu Yongling; Heldebrant Charles; Smith Richard; Giachetti Cristina; Gallarda James; Busch Michael P
Dynamics of viremia in early hepatitis C virus infection.
Transfusion 2005;45(6):994-1002.
2005: Fiebig Eberhard W; Heldebrant Charles M; Smith Richard I F; Conrad Andrew J; Delwart Eric L; Busch Michael P
Intermittent low-level viremia in very early primary HIV-1 infection.
Journal of acquired immune deficiency syndromes (1999) 2005;39(2):133-7.
2005: Utter Garth H; Owings John T; Lee Tzong-Hae; Paglieroni Teresa G; Reed William F; Gosselin Robert C; Holland Paul V; Busch Michael P
Microchimerism in transfused trauma patients is associated with diminished donor-specific lymphocyte response.
The Journal of trauma 2005;58(5):925-31; discussion 931-2.
2005: Busch M P; Tobler L H; Saldanha J; Caglioti S; Shyamala V; Linnen J M; Gallarda J; Phelps B; Smith R I F; Drebot M; Kleinman S H
Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003.
Transfusion 2005;45(4):492-9.
2005: Tobler L H; Bianco C; Glynn S A; Schreiber G B; Dille B J; Prince H E; Lanciotti R S; Linnen J M; Gallarda J; Shyamala V; Smith D; Kleinman S H; Busch M P;
Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic.
Transfusion 2005;45(4):480-6.
2005: Busch Michael P; Glynn Simone A; Stramer Susan L; Strong D Michael; Caglioti Sally; Wright David J; Pappalardo Brandee; Kleinman Steven H;
A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors.
Transfusion 2005;45(2):254-64.
2004: Lee Tzong-Hae; Chafets Daniel M; Busch Michael P; Murphy Edward L
Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;31(4):275-82.
2004: Custer Brian; Tomasulo Peter A; Murphy Edward L; Caglioti Sally; Harpool Dennis; McEvoy Patrick; Busch Michael P
Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making.
Transfusion 2004;44(11):1547-54.
2004: Utter Garth H; Owings John T; Lee Tzong-Hae; Paglieroni Teresa G; Reed William F; Gosselin Robert C; Holland Paul V; Busch Michael P
Blood transfusion is associated with donor leukocyte microchimerism in trauma patients.
The Journal of trauma 2004;57(4):702-7; discussion 707-8.
2004: Custer Brian; Johnson Eric S; Sullivan Sean D; Hazlet Tom K; Ramsey Scott D; Hirschler Nora V; Murphy Edward L; Busch Michael P
Quantifying losses to the donated blood supply due to donor deferral and miscollection.
Transfusion 2004;44(10):1417-26.
2004: Fiebig Eberhard W; Busch Michael P
Emerging infections in transfusion medicine.
Clinics in laboratory medicine 2004;24(3):797-823, viii.
2004: Kuhns Mary C; Kleinman Steven H; McNamara Anne L; Rawal Bhupat; Glynn Simone; Busch Michael P;
Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Transfusion 2004;44(9):1332-9.
2004: Stramer Susan L; Glynn Simone A; Kleinman Steven H; Strong D Michael; Caglioti Sally; Wright David J; Dodd Roger Y; Busch Michael P;
Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
The New England journal of medicine 2004;351(8):760-8.
2004: Asmuth David M; Busch Michael P; Laycock Megan E; Mohr Beth A; Kalish Leslie A; van der Horst Charles M;
Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection.
Antiviral research 2004;63(2):123-31.
2004: Barbour Jason D; Hecht Frederick M; Wrin Terri; Liegler Teri J; Ramstead Clarissa A; Busch Michael P; Segal Mark R; Petropoulos Christos J; Grant Robert M
Persistence of primary drug resistance among recently HIV-1 infected adults.
AIDS (London, England) 2004;18(12):1683-9.
2004: Roland Michelle E; Elbeik Tarek A; Kahn James O; Bamberger Joshua D; Coates Thomas J; Krone Melissa R; Katz Mitchell H; Busch Michael P; Martin Jeffrey N
HIV RNA testing in the context of nonoccupational postexposure prophylaxis.
The Journal of infectious diseases 2004;190(3):598-604.
2004: Barbour Jason D; Hecht Frederick M; Wrin Terri; Segal Mark R; Ramstead Clarissa A; Liegler Teri J; Busch Michael P; Petropoulos Christos J; Hellmann Nicholas S; Kahn James O; Grant Robert M
Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection.
The Journal of infectious diseases 2004;190(2):251-6.
2004: Murphy Edward L; David Connor J; McEvoy Patrick; Hirschler Nora; Busch Michael P; Roberts Paula; Nguyen Kim-Ank; Reich Pascale
Estimating blood donor loss due to the variant CJD travel deferral.
Transfusion 2004;44(5):645-50.
2004: Delwart E L; Kalmin N D; Jones T S; Ladd D J; Foley B; Tobler L H; Tsui R C P; Busch M P
First report of human immunodeficiency virus transmission via an RNA-screened blood donation.
Vox sanguinis 2004;86(3):171-7.
2004: Busch Michael P
Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2004;11(1):26-32.
2004: McAuley Joan D; Caglioti Sally; Williams Robert C; Robertson Gene F; Morgan Larry; Tobler Leslie H; Busch Michael P
Clinical significance of nondiscriminated reactive results with the Chiron Procleix HIV-1 and HCV assay.
Transfusion 2004;44(1):91-6.
2003: Delwart Eric L; Orton Sharyn; Parekh Bharat; Dobbs Trudy; Clark Kenneth; Busch Michael P
Two percent of HIV-positive U.S. blood donors are infected with non-subtype B strains.
AIDS research and human retroviruses 2003;19(12):1065-70.
2003: Tobler Leslie H; Stramer Susan L; Lee Stephen R; Masecar Barbara L; Peterson Jon E; Davis E Anne; Andrews William E; Brodsky Jaye P; Kleinman Steven H; Phelps Bruce H; Busch Michael P
Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening.
Transfusion 2003;43(10):1452-9.
2003: Operskalski Eva A; Mosley James W; Tobler Leslie H; Fiebig Eberhard W; Nowicki Marek J; Mimms Larry T; Gallarda James; Phelps Bruce H; Busch Michael P;
HCV viral load in anti-HCV-reactive donors and infectivity for their recipients.
Transfusion 2003;43(10):1433-41.
2003: Drew W Lawrence; Chou Sunwen; Mohr Beth A; Assmann Susan F; Miner Richard C; Laycock Megan E; Busch Michael P;
Absence of activation of CMV by blood transfusion to HIV-infected, CMV-seropositive patients.
Transfusion 2003;43(10):1351-7.
2003: Fiebig Eberhard W; Wright David J; Rawal Bhupat D; Garrett Patricia E; Schumacher Richard T; Peddada Lorraine; Heldebrant Charles; Smith Richard; Conrad Andrew; Kleinman Steven H; Busch Michael P
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.
AIDS (London, England) 2003;17(13):1871-9.
2003: Pellett P E; Wright D J; Engels E A; Ablashi D V; Dollard S C; Forghani B; Glynn S A; Goedert J J; Jenkins F J; Lee T-H; Neipel F; Todd D S; Whitby D; Nemo G J; Busch M P;
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors.
Transfusion 2003;43(9):1260-8.
2003: Busch Michael P; Tobler Leslie H; Gerlich Wolfram H; Schaefer Stephan; Giachetti Cristina; Smith Richard
Very low level viremia in HCV infectious unit missed by NAT.
Transfusion 2003;43(8):1173-4.
2003: Rawal Bhupat D; Degula Azucena; Lebedeva Ludmila; Janssen Robert S; Hecht Frederick M; Sheppard Haynes W; Busch Michael P
Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection.
Journal of acquired immune deficiency syndromes (1999) 2003;33(3):349-55.
2003: Fang C T; Field S P; Busch M P; Heyns A du P
Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
Vox sanguinis 2003;85(1):9-19.
2003: Biswas Robin; Tabor Edward; Hsia Chu Chieh; Wright David J; Laycock Megan E; Fiebig Eberhard W; Peddada Lorraine; Smith Richard; Schreiber George B; Epstein Jay S; Nemo George J; Busch Michael P
Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection.
Transfusion 2003;43(6):788-98.
2003: Kleinman Steven H; Kuhns Mary C; Todd Deborah S; Glynn Simone A; McNamara Anne; DiMarco Anthony; Busch Michael P;
Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening.
Transfusion 2003;43(6):696-704.
2003: Alves Katia; Shafer Kimberly Page; Caseiro Marcos; Rutherford George; Falcao Maria Elvira; Sucupira Maria Cecília; Busch Michael P; Rawal Bhupat D; Diaz Ricardo S
Risk factors for incident HIV infection among anonymous HIV testing site clients in Santos, Brazil: 1996-1999.
Journal of acquired immune deficiency syndromes (1999) 2003;32(5):551-9.
2003: Fang Chyang T; Tobler Leslie H; Haesche Carmen; Busch Michael P; Phelps Bruce; Leparc German
Fluctuation of HCV viral load before seroconversion in a healthy volunteer blood donor.
Transfusion 2003;43(4):541-4.
2003: Asmuth David M; Kalish Leslie A; Laycock Megan E; Murphy Edward L; Mohr Beth A; Lee Tzong-Hae; Gallarda James; Giachetti Cristina; Dollard Sheila C; van der Horst Charles M; Grant Robert M; Busch Michael P;
Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infection.
Transfusion 2003;43(4):451-8.
2003: Roback John D; Drew W Lawrence; Laycock Megan E; Todd Deborah; Hillyer Christopher D; Busch Michael P
CMV DNA is rarely detected in healthy blood donors using validated PCR assays.
Transfusion 2003;43(3):314-21.
2003: Drew W Lawrence; Tegtmeier Gary; Alter Harvey J; Laycock Megan E; Miner Richard C; Busch Michael P
Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients.
Transfusion 2003;43(3):309-13.
2003: Busch Michael P; Kleinman Steven H; Nemo George J
Current and emerging infectious risks of blood transfusions.
JAMA : the journal of the American Medical Association 2003;289(8):959-62.
2003: Sharma Usha K; Stramer Susan L; Wright David J; Glynn Simone A; Hermansen Sigurd; Schreiber George B; Kleinman Steven H; Busch Michael P;
Impact of changes in viral marker screening assays.
Transfusion 2003;43(2):202-14.
2003: Ariga Hiromichi; Lee Tzong-Hae; Laycock Megan E; Mohr Beth A; Kalish Leslie A; Yomtovian Roslyn; Gernsheimer Terry; Busch Michael P;
Residual WBC subsets in filtered prestorage RBCs.
Transfusion 2003;43(1):98-106.
2002: Hahn Judith A; Page-Shafer Kimberly; Lum Paula J; Bourgois Philippe; Stein Ellen; Evans Jennifer L; Busch Michael P; Tobler Leslie H; Phelps Bruce; Moss Andrew R
Hepatitis C virus seroconversion among young injection drug users: relationships and risks.
The Journal of infectious diseases 2002;186(11):1558-64.
2002: Tobler L H; Dockter Janel; Stramer S L; Kleinman S H; Todd D; Giachetti Cristina; Busch M P
Use of the Procleix HIV-1 and HCV discriminatory assays to detect HIV and HCV RNA in whole blood.
Transfusion 2002;42(11):1525-7.
2002: Grant Robert M; Hecht Frederick M; Warmerdam Maria; Liu Lea; Liegler Teri; Petropoulos Christos J; Hellmann Nicholas S; Chesney Margaret; Busch Michael P; Kahn James O
Time trends in primary HIV-1 drug resistance among recently infected persons.
JAMA : the journal of the American Medical Association 2002;288(2):181-8.
2002: Drew W Lawrence; Chou Sunwen; Miner Richard C; Mohr Beth A; Busch Michael P; van der Horst Charles M; Asmuth David M; Kalish Leslie A
Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis.
The Journal of infectious diseases 2002;186(1):114-7.
2002: Hecht Frederick M; Busch Michael P; Rawal Bhupat; Webb Marcy; Rosenberg Eric; Swanson Melinda; Chesney Margaret; Anderson Jennifer; Levy Jay; Kahn James O
Use of laboratory tests and clinical symptoms for identification of primary HIV infection.
AIDS (London, England) 2002;16(8):1119-29.
2002: Weinstock Hillard; Dale Monica; Gwinn Marta; Satten Glen A; Kothe Denise; Mei Joanne; Royalty Janet; Linley Laurie; Fridlund Carol; Parekh Bharat; Rawal Bhupat D; Busch Michael P; Janssen Robert S
HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United States.
Journal of acquired immune deficiency syndromes (1999) 2002;29(5):478-83.
2002: Machado Daisy M; Delwart Eric L; Diaz Ricardo S; de Oliveira Carlos F; Alves Katia; Rawal Bhupat D; Sullivan Marian; Gwinn Marta; Clark Kenneth A; Busch Michael P
Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors.
AIDS (London, England) 2002;16(1):113-9.
2001: Tobler L H; Stramer S L; Kleinman S H; Brodsky J P; Todd D S; Busch M P
Misclassification of HCV-viremic blood donors as indeterminate by RIBA 3.0 because of human superoxide dismutase reactivity.
Transfusion 2001;41(12):1625-6.
2001: Ariga H; Ohto H; Busch M P; Imamura S; Watson R; Reed W; Lee T H
Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis.
Transfusion 2001;41(12):1524-30.
2001: Roback J D; Hillyer C D; Drew W L; Laycock M E; Luka J; Mocarski E S; Slobedman B; Smith J W; Soderberg-Naucler C; Todd D S; Woxenius S; Busch M P
Multicenter evaluation of PCR methods for detecting CMV DNA in blood donors.
Transfusion 2001;41(10):1249-57.
2001: Yomtovian R; Gernsheimer T; Assmann S F; Mohandas K; Lee T H; Kalish L A; Busch M P;
WBC reduction in RBC concentrates by prestorage filtration: multicenter experience.
Transfusion 2001;41(8):1030-6.
2001: Kruskall M S; Lee T H; Assmann S F; Laycock M; Kalish L A; Lederman M M; Busch M P;
Survival of transfused donor white blood cells in HIV-infected recipients.
Blood 2001;98(2):272-9.
2001: Busch M P
Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients.
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2001;8(3):200-6.
2001: Schreiber G B; Glynn S A; Busch M P; Sharma U K; Wright D J; Kleinman S H;
Incidence rates of viral infections among repeat donors:are frequent donors safer?
Transfusion 2001;41(6):730-5.
2001: Lee T H; Reed W; Mangawang-Montalvo L; Watson J; Busch M P
Donor WBCs can persist and transiently mediate immunologic function in a murine transfusion model: effects of irradiation, storage, and histocompatibility.
Transfusion 2001;41(5):637-42.
2001: Collier A C; Kalish L A; Busch M P; Gernsheimer T; Assmann S F; Lane T A; Asmuth D M; Lederman M M; Murphy E L; Kumar P; Kelley M; Flanigan T P; McMahon D K; Sacks H S; Kennedy M S; Holland P V;
Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2001;285(12):1592-601.
2001: Lee T H; Montalvo L; Chrebtow V; Busch M P
Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma.
Transfusion 2001;41(2):276-82.
2001: Donahue J; Gilpin E; Lee T H; Busch M P; Croft M; Carrier E
Microchimerism does not induce tolerance and sustains immunity after in utero transplantation.
Transplantation 2001;71(3):359-68.
2001: Reed W F; Lee T L; Trachtenberg E; Vinson M; Busch M P
Detection of microchimerism by PCR is a function of amplification strategy.
Transfusion 2001;41(1):39-44.
2001: Chamberland M E; Alter H J; Busch M P; Nemo G; Ricketts M
Emerging infectious disease issues in blood safety.
Emerging infectious diseases 2001;7(3 Suppl):552-3.
2000: de Oliveira C F; Diaz R S; Machado D M; Sullivan M T; Finlayson T; Gwinn M; Lackritz E M; Williams A E; Kessler D; Operskalski E A; Mosley J W; Busch M P
Surveillance of HIV-1 genetic subtypesand diversity in the US blood supply.
Transfusion 2000;40(11):1399-406.
2000: Fiebig E; Hirschkorn D F; Maino V C; Grass J A; Lin L; Busch M P
Assessment of donor T-cell function in cellular blood components by the CD69 induction assay: effects of storage, gamma radiation, and photochemical treatment.
Transfusion 2000;40(7):761-70.
2000: Ling A E; Robbins K E; Brown T M; Dunmire V; Thoe S Y; Wong S Y; Leo Y S; Teo D; Gallarda J; Phelps B; Chamberland M E; Busch M P; Folks T M; Kalish M L
Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period.
JAMA : the journal of the American Medical Association 2000;284(2):210-4.
2000: Lederman M M; Kalish L A; Asmuth D; Fiebig E; Mileno M; Busch M P
'Modeling' relationships among HIV-1 replication, immune activation and CD4+ T-cell losses using adjusted correlative analyses.
AIDS (London, England) 2000;14(8):951-8.
2000: Tobler L H; Tegtmeier G; Stramer S L; Quan S; Dockter J; Giachetti C; Busch M P
Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays:justification and rational implementation.
Transfusion 2000;40(1):15-24.
2000: Busch M P; Tobler L H; Tegtmeier G; Polito A; Quan S; Hirschler N V; Dockter J; Giachetti C; Mimms L
Use of third-generation hepatitis C virus (HCV) enzyme immunoassay (EIA) to resolve second-generation HCV EIA-reactive and second-generation recombinant immunoblot assay-indeterminate blood samples: data to support current Food and Drug Administration guidance on HCV lookback.
Transfusion 2000;40(1):10-4.
2000: Busch M P
Comparative methods of viral gene amplification.
Developments in biologicals 2000;102():69-80.
1999: McFarland W; Busch M P; Kellogg T A; Rawal B D; Satten G A; Katz M H; Dilley J; Janssen R S
Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San Francisco.
Journal of acquired immune deficiency syndromes (1999) 1999;22(5):484-9.
1999: Lane T A; Gernsheimer T B; Busch M P; Holland P
Transfusion of the HIV-seropositive patient.
Transfusion medicine reviews 1999;13(4):334.
1999: Sabino E C; Salles N; Sáez-Alquézar A; Ribeiro-dos-Santos G; Chamone D F; Busch M P
Estimated risk of transfusion-transmitted HIV infection in São Paulo, Brazil.
Transfusion 1999;39(10):1152-3.
1999: Diaz R S; De Oliveira C F; Pardini R; Operskalski E; Mayer A J; Busch M P
HIV type 1 tat gene heteroduplex mobility assay as a tool to establish epidemiologic relationships among HIV type 1-infected individuals.
AIDS research and human retroviruses 1999;15(13):1151-6.
1999: Diaz R S; Kallas E G; Castelo A; Rawal B D; Busch M P
Use of a new 'less-sensitive enzyme immunoassay' testing strategy to identify recently infected persons in a Brazilian prison: estimation of incidence and epidemiological tracing.
AIDS (London, England) 1999;13(11):1417-8.
1999: Lee T H; Paglieroni T; Ohto H; Holland P V; Busch M P
Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients.
Blood 1999;93(9):3127-39.
1998: Reed W; Lee T H; Vichinsky E P; Lubin B H; Busch M P
Sample suitability for the detection of minor white cell populations (microchimerism) by polymerase chain reaction.
Transfusion 1998;38(11-12):1041-5.
1998: Wilkinson D A; Operskalski E A; Busch M P; Mosley J W; Koup R A
A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness.
The Journal of infectious diseases 1998;178(4):1163-6.
1998: Murphy E L; Busch M P; Tong M; Cornett P; Vyas G N
A prospective study of the risk of transfusion-acquired viral infections.
Transfusion medicine (Oxford, England) 1998;8(3):173-8.
1998: Janssen R S; Satten G A; Stramer S L; Rawal B D; O'Brien T R; Weiblen B J; Hecht F M; Jack N; Cleghorn F R; Kahn J O; Chesney M A; Busch M P
New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.
JAMA : the journal of the American Medical Association 1998;280(1):42-8.
1998: Lee T H; Stromberg R R; Heitman J W; Sawyer L; Hanson C V; Busch M P
Distribution of HIV type 1 (HIV-1) in blood components: detection and significance of high levels of HIV-1 associated with platelets.
Transfusion 1998;38(6):580-8.
1998: García Lerma J G; Yamamoto S; Gómez-Cano M; Soriano V; Green T A; Busch M P; Folks T M; Heneine W
Measurement of human immunodeficiency virus type 1 plasma virus load based on reverse transcriptase (RT) activity: evidence of variabilities in levels of virion-associated RT.
The Journal of infectious diseases 1998;177(5):1221-9.
1998: Lee T H; Sakahara N S; Fiebig E W; Hirschkorn D F; Johnson D K; Busch M P
Quantitation of white cell subpopulations by polymerase chain reaction using frozen whole-blood samples. Viral Activation Transfusion Study.
Transfusion 1998;38(3):262-70.
1998: Busch M P
Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.
Vox sanguinis 1998;74 Suppl 2():147-54.
1998: Reesink H W; Engelfriet C P; Vrielink H; Krusius T; Lankinen M; Flanagan P; Barbara J; Gill P; Dodd R Y; Busch M P; Prati D; Mozzi F; Sirchia G; Diekamp U; Epstein J S; Tabor E; Martin-Vega C; Hernândez J M
Consequences of nucleic acid amplification testing for blood transfusion centres.
Vox sanguinis 1998;74(4):263-70.
1997: Fiebig E W; Johnson D K; Hirschkorn D F; Knape C C; Webster H K; Lowder J; Busch M P
Lymphocyte subset analysis on frozen whole blood.
Cytometry 1997;29(4):340-50.
1997: Busch M P; Dodd R Y; Lackritz E M; AuBuchon J P; Birkmeyer J D; Petersen L R
Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study Group.
Transfusion 1997;37(10):1003-11.
1997: Busch M P; Glynn S A; Schreiber G B
Potential increased risk of virus transmission due to exclusion of older donors because of concern over Creutzfeldt-Jakob disease. The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study.
Transfusion 1997;37(10):996-1002.
1997: Operskalski E A; Stram D O; Busch M P; Huang W; Harris M; Dietrich S L; Schiff E R; Donegan E; Mosley J W
Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group.
American journal of epidemiology 1997;146(8):655-61.
1997: Tobler L H; Kaufman E; Gefter N; Schable C; Busch M P
Use of human immunodeficiency virus (HIV) type 1 and 2 recombinant strip immunoblot assay to resolve enzyme immunoassay anti-HIV-2-repeatably reactive samples after anti-HIV-1/2 combination enzyme immunoassay screening.
Transfusion 1997;37(9):921-5.
1997: Tobler L H; Busch M P
History of posttransfusion hepatitis.
Clinical chemistry 1997;43(8 Pt 2):1487-93.
1997: Operskalski E A; Mosley J W; Busch M P; Stram D O
Influences of age, viral load, and CD4+ count on the rate of progression of HIV-1 infection to AIDS. Transfusion Safety Study Group.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;15(3):243-4.
1997: Operskalski E A; Busch M P; Mosley J W; Stram D O
Comparative rates of disease progression among persons infected with the same or different HIV-1 strains. The Transfusion Safety Study Group.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;15(2):145-50.
1997: Busch M P; Satten G A
Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure.
The American journal of medicine 1997;102(5B):117-24; discussion 125-6.
1997: Operskalski E A; Busch M P; Mosley J W; Kedes D H
Blood donations and viruses.
Lancet 1997;349(9061):1327.
1997: Diaz R S; Zhang L; Busch M P; Mosley J W; Mayer A
Divergence of HIV-1 quasispecies in an epidemiologic cluster.
AIDS (London, England) 1997;11(4):415-22.
1997: Zhang L; Diaz R S; Ho D D; Mosley J W; Busch M P; Mayer A
Host-specific driving force in human immunodeficiency virus type 1 evolution in vivo.
Journal of virology 1997;71(3):2555-61.
1997: Adams M R; Johnson D K; Busch M P; Schembri C T; Hartz T P; Heaton W A
Automatic volumetric capillary cytometry for counting white cells in white cell-reduced plateletpheresis components.
Transfusion 1997;37(1):29-37.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Michael Busch

Research Profile (preview)

Living Beings

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Michael Busch (preview)

All Publications